Abstract: The present disclosure relates to electronic devices that include a composition that actively generates a gaseous oxidizing agent component within the interior gas space of the electronic device. The present disclosure also involves related methods.

Abstract: The present disclosure relates to electronic devices that include a composition that actively generates a gaseous oxidizing agent component within the interior gas space of the electronic device. The present disclosure also involves related methods.

Abstract: The present disclosure relates to electronic devices that include a composition that actively generates a gaseous oxidizing agent component within the interior gas space of the electronic device. The present disclosure also involves related methods.

Abstract: The present disclosure relates to electronic devices that include a composition that actively generates a gaseous oxidizing agent component within the interior gas space of the electronic device. The present disclosure also involves related methods.

Abstract: The present disclosure relates to electronic devices that include a composition that actively generates a gaseous oxidizing agent component within the interior gas space of the electronic device. The present disclosure also involves related methods.

Abstract: A sandal including a sole having a front region and a back region and an interior side and an exterior side, having a first opening in or near the back region at the interior side and a second opening in or near the back region at the exterior side. A primary strap is threaded through the first opening, then looped around the back region, and threaded through the second opening, thereby defining a heel region of the primary strap between the first opening and the second opening. The sandal further includes an adjustable securement strap that attaches on one side to the interior side of the heel region of the primary strap and on the other side to the exterior side of the heel region of the primary strap.

Abstract: A sandal including a sole having a front region and a back region and an interior side and an exterior side, that includes a first opening located in said front region, a second opening in or near said back region at said interior side and a third opening in or near said back region at said exterior side, and a strap, which includes a plurality of sections, having a first end and a second end and wherein said first end is threaded upwardly through said front opening, through said second opening and looped around said back region, and through said third opening, thereby defining a heel region between said second opening and said third opening.

Abstract: A sandal including a sole having a front region and a back region and an interior side and an exterior side, that includes a first opening located in said front region, a second opening in or near said back region at said interior side and a third opening in or near said back region at said exterior side, and a strap, which includes a plurality of sections, having a first end and a second end and wherein said first end is threaded upwardly through said front opening, through said second opening and looped around said back region, and through said third opening, thereby defining a heel region between said second opening and said third opening.

Abstract: The present invention relates to compounds of formula I or a pharmaceutically acceptable salt thereof wherein R2 is 2-hydroxymethylpyrrolidin-1-yl, or NHCH(R4)CH(R3)OH, wherein R3 is hydrogen or methyl and R4 is methyl, ethyl or isopropyl; R6 is 3-nitrophenylamino, 3,4-dimethoxybenzylamino, 3-iodobenzyl-amino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino; R9 is isopropyl or cyclopentanyl. In a further aspect, the invention relates to pharmaceutical compositions comprising said compounds, and the use thereof in treating antiproliferative disorders and or viral disorders.

Abstract: The present invention relates to compounds of formula I or a pharmaceutically acceptable salt thereof wherein R2 is 2-hydroxymethylpyrrolidin-1-yl, or NHCH(R4)CH(R3)OH, wherein R3 is hydrogen or methyl and R4 is methyl, ethyl or isopropyl; R6 is 3-nitrophenylamino, 3,4-dimethoxybenzylamino, 3-iodobenzyl-amino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino; R9 is isopropyl or cyclopentanyl. In a further aspect, the invention relates to pharmaceutical compositions comprising said compounds, and the use thereof in treating antiproliferative disorders and or viral disorders.